ABBV
AbbVie Inc.
Stock
$263.29−2.99 (−1.12%)Close Sep 29, 2026
| EBITDA (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $17.6B | +50.4% | 5.7% | 7.1% |
| EBITDA (TTM) | $17.6B |
|---|---|
| YoY | +50.4% |
| 5-year CAGR | 5.7% |
| 10-year CAGR | 7.1% |
EBITDA
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $15.8B | +60.0% |
| 2024 | $9.9B | −26.7% |
| 2023 | $13.5B | −28.5% |
| 2022 | $18.9B | +0.9% |
| 2021 | $18.7B | +55.7% |
| 2020 | $12.0B | −10.5% |
| 2019 | $13.4B | +96.2% |
| 2018 | $6.9B | −31.3% |
| 2017 | $10.0B | +2.1% |
| 2016 | $9.8B | +22.8% |
| 2015 | $8.0B | +109.6% |
| 2014 | $3.8B | −37.3% |
| 2013 | $6.1B | −4.6% |
| 2012 | $6.3B | +53.6% |
| 2011 | $4.1B | — |